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a b s t r a c t
SHAPE technology was used to analyze RNA secondary structure of the 50 most 474 nts of the MHV-A59
genome encompassing the minimal 50 cis-acting region required for defective interfering RNA replica-
tion. The structures generated were in agreement with previous characterizations of SL1 through SL4
and two recently predicted secondary structure elements, S5 and SL5A. SHAPE provided biochemical
support for four additional stem–loops not previously functionally investigated in MHV. Secondary
structure predictions for 50 regions of MHV-A59, BCoV and SARS-CoV were similar despite high sequence
divergence. The pattern of SHAPE reactivity of in virio genomic RNA, ex virio genomic RNA, and in vitro
synthesized RNA was similar, suggesting that binding of N protein or other proteins to virion RNA fails to
protect the RNA from reaction with lipid permeable SHAPE reagent. Reverse genetic experiments
suggested that SL5C and SL6 within the nsp1 coding sequence are not required for viral replication.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Coronaviruses (CoVs) comprise a group of enveloped RNA viruses,
with large positive-sense, single-stranded RNA genomes of 25–31 kb,
which cause respiratory, enteric, hepatic and neurological diseases in a
broad range of vertebrate species, including humans (Stadler et al.,
2003; Weiss and Leibowitz, 2007). Mouse Hepatitis Virus (MHV) is the
most extensively studied prototypical CoV, and provides a platform to
study CoV replication and transcription (Snijder et al., 2003; Weiss and
Leibowitz, 2007). Cells infected with MHV contain genomic RNA and
six to seven subgenomic mRNAs that make up a 30 co-terminal nested
set (Sawicki et al., 2007). At their 50 ends subgenomic mRNAs contain
a 72 nucleotide leader sequence identical to the 50 72 nucleotides of
virion RNA (Sawicki et al., 2007). The entire leader sequence is not
present in the genome sequence 50-adjacent to the remainder (body)
of the mRNA rather a short 7 nucleotide sequence known as a
transcriptional regulatory sequence (TRS), also present at the 30end
of the leader sequence at the 50end of the genome, is found at these
positions (Sawicki et al., 2007). The TRS plays a crucial role in the
discontinuous transcription mechanism by which the subgenomic
mRNAs are synthesized, serving as signals (and sites) for leader body
joining during transcription of the negative strand templates for
positive sense subgenomic mRNAs (Sawicki et al., 2007). Several
studies employing defective interfering (DI) RNAs as model replicons
showed that approximately 400–800 nucleotides at the 50 end and
400 nts at the 30 end of MHV RNA genome act as cis-acting sequences
necessary for replication (Kim et al., 1993; Lin and Lai, 1993; Luytjes
et al., 1996), with the minimal length of 50 sequence that supported DI
replication being 474 nts (Kim et al., 1993). These cis-acting sequences
in MHV RNA have been presumed to fold into secondary and higher-
order structures functioning as signals important for RNA–RNA inter-
actions and for binding of viral and cellular proteins during RNA
replication, translation and potentially encapsidation (Brian and Baric,
2005; Liu and Leibowitz, 2010; Liu et al., 2009b).
MHV is closely related to Bovine Coronavirus (BCoV) and SARS-
coronavirus (SARS-CoV) in the betacoronavirus genus (Gorbalenya
et al., 2006). The secondary structures in the 50-end-proximal
genomic regions of these three viruses are largely conserved even
though the nucleotide sequences are relatively divergent (Chen
and Olsthoorn, 2010; Guan et al., 2012). A series of studies by
consensus covariation modeling, chemical probing, and nuclear
magnetic resonance (NMR) spectroscopy in conjunction with
reverse genetics have been carried out to characterize the pre-
dicted secondary structures of cis-acting sequences in the 50UTR
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and the N-terminal nsp1 coding region of MHV and BoCV, and to
identify their functional roles in viral replication (Brown et al.,
2007; Chen and Olsthoorn, 2010; Guan et al., 2012, 2011; Li et al.,
2008; Liu et al., 2009a, 2007; Yang et al., 2011). The structurally
bipartite stem–loop SL1 (nts 5–40) (Li et al., 2008) and SL2 a
uCUYG(U)a-like tetraloop stacked on a ﬁve base pair stem (nts 42–
56) (Liu et al., 2009a, 2007) in the MHV 50UTR (see Fig. 1A) have
been functionally characterized and are required for subgenomic
RNA synthesis; the structure of SL2 has been determined at atomic
resolution (Lee et al., 2011). In MHV, a base pairing scheme can be
drawn which places the TRS (transcriptional regulatory sequence)
into the loop of SL3 (Chen and Olsthoorn, 2010), but the stem is
not predicted to be stable at 37 1C (Liu et al., 2007). SL4 (nts 80–
130) (see Fig. 1A) seems to function as a poorly understood
“spacer” element that may optimally orient adjacent stem–loops;
the presence of an SL4 is required to drive subgenomic RNA
synthesis with little dependence on nucleotide sequence (Yang
et al., 2011). Recently the Brian group determined that a stem loop
that they designated SLIV (SL5A in our model; see Fig. 1A),
spanning nts 171–225 and thus extending into the nsp1 coding
sequence, was required for optimal replication of MHV (Guan
et al., 2011). The individual stem–loop structures contained in the
50UTRs of related betacoronaviruses are largely interchangeable,
with the exception of their TRSs (Guan et al., 2011; Kang et al.,
2006; Li et al., 2008). However, the 32 nts in the 50 side of S5
(nts 142–173) in the BCoV 50UTR, which has been predicted to be
single-stranded in previous thermodynamic and phylogenetic
models (Guan et al., 2011), cannot directly replace the equivalent
sequences in MHV without genetic adaptation (Guan et al., 2012,
2011). These adaptations suggested that a long range interaction
between nts 141 and 170 with nts 332 and 363 (S5, Fig. 1A) is
required for optimal viral replication (Guan et al., 2012).
A chemical method termed SHAPE (selective 20-hydroxyl acylation
and primer extension) used to determine the overall secondary
structure for any length of RNA sequence under different biological
conditions has been developed (Merino et al., 2005; Watts et al., 2009;
Wilkinson et al., 2008). In SHAPE chemistry an electrophilic reagent,
1M7 (1-methyl-7-nitroisatoic anhydride) or NMIA (N-methylisatoic
anhydride), selectively acylates the ribose 20-hydroxyl group
of a ﬂexible nucleotide in a RNA and forms a stable 20-O-adduct
(nucleotide 20-ester) (Merino et al., 2005; Mortimer andWeeks, 2007).
SHAPE has important advantages over traditional biochemical mea-
surements of RNA secondary structure. SHAPE provides quantitative
data for addressing structure–function relationships in RNA. SHAPE-
derived RNA secondary structure determinations yield models of RNAs
of known structure that include 85–95% of the accepted base pairs
(Deigan et al., 2009; Kladwang et al., 2011). An additional advantage of
SHAPE is that reactivity is not inﬂuenced by the base identity of the
nucleotide sequence (Mortimer and Weeks, 2007; Wilkinson et al.,
2009).
The hypothesis underlying this work is that the cis-acting 50-
most 474 nts of MHV-A59, including the 50UTR (nts 1–209) and the
immediately adjacent 50 region of the nsp1 coding sequence (nts
210–474), form stem–loop structures important for viral replica-
tion and viral RNA synthesis. We use SHAPE methodology to
determine the secondary structure of the 50-most 474 nts of
MHV-A59 genome, which corresponds to the minimal 50 cis-acting
regulatory region mapped in defective interference (DI) experi-
ments (Kim et al., 1993; Luytjes et al., 1996). This region contains
the 50UTR and extends into nsp1, a 28-kDa amino-terminal protein
(also known as p28) which is the ﬁrst mature protein processed
from the gene 1 polyprotein (Denison and Perlman, 1987). The
N-terminus of the BCoV nsp1 coding region is predicted to contain
stem–loop structures supported by RNase structure probing and
by nucleotide covariation among closely related betacorona-
viruses, and some of these secondary structures act as cis-acting
elements required for BCoV DI RNA replication (Brown et al., 2007;
Gustin et al., 2009). In this work we compare the RNA secondary
structure of the 50 474 nts of MHV-A59 genome in the virion
(in virio) to the structure of genomic RNA that has been gently
extracted and deproteinized (ex virio) and to an in vitro RNA
transcript targeting the 50-most 474 nts, in an effort to identify
differences in SHAPE reactivity among the three biological states of
RNA from which we might infer putative protein binding
sequences/structures within this region of the genome. To further
assess the validity of the structural model generated by SHAPE and
Fig. 1. Comparison of secondary structure models of the 50- most 474 nts of MHV-A59, BCoV, and SARS-CoV. (A) The MHV-A59 model was generated by SHAPE analysis.
Italicized labels indicate structural elements essential for virus recovery and subgenomic () sense RNA synthesis. Bolded labels indicate structural elements that when
mutated result in large decreases in the ability of viral genomes to replicate, and thus have a signiﬁcant role in viral replication. (B) The thermodynamically most stable
models of the corresponding 50 474 nts of BCoV-Mebus and (C) SARS-CoV were generated by RNAstructure. The gray and italicized text denotes the core leader TRS regions.
The gray AUGs represent the start codons of nsp1 in the three viruses. Note that the nomenclature for BCoV is not equivalent to that of previous studies by the Brian
Laboratory (Brown et al., 2007; Guan et al., 2012, 2011); SL1 and SL2 correspond to SLI, SL3 to SLII, SL4 to SLIII, SL5A to SLIV, SL5B to SLV, SL5C to SLVI, S5 to a long-range
RNA–RNA interaction, and SL6 to SLVIII.
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to identify common replication signals in CoVs, we compare the
secondary structures obtained by SHAPE with our current model
of the ﬁrst 140 nts of the MHV 50UTR which contain SL1 (Li et al.,
2008), SL2 (Liu et al., 2009a, 2007) and SL4 (Yang et al., 2011) and
with the secondary structures in the 30 adjacent region predicted
by the Brian laboratory (Brown et al., 2007; Guan et al., 2012, 2011;
Raman et al., 2003; Raman and Brian, 2005) and by Chen and
Olsthoorn (2010). We employ a reverse genetic approach to
examine the functional roles in virus replication of two novel
secondary structures predicted by SHAPE analysis.
Results and discussion
SHAPE analysis of MHV-A59 50 region of RNA
In vitro synthesized and refolded RNA corresponding to nts
1–489 plus a 24-nucleotide unstructured region were separately
reacted with the SHAPE reagents 1M7 and NMIA, and SHAPE
reactivity at each position was assessed by primer extension as
described in Materials and methods. In vitro synthesized RNA was
used as the initial substrate for SHAPE analysis because all
previous biochemical analyses of the RNA secondary structure of
the 50 region of coronaviruses have used in vitro synthesized RNAs
(Brown et al., 2007; Chen and Olsthoorn, 2010; Guan et al., 2012,
2011; Li et al., 2008; Liu et al., 2009a; Raman et al., 2003; Raman
and Brian, 2005; Yang et al., 2011), thus allowing a direct
comparison of results. Although 1M7 provides a faster reaction
rate and more accurate information regarding RNA structure than
NMIA (Mortimer and Weeks, 2007) we utilized both 1M7 and
NMIA in order to compare the results obtained with the two
chemicals and to provide a basis for subsequent in virio genomic
RNA SHAPE experiments which require NMIA being able to
penetrate virus envelopes (Wilkinson et al., 2008). The SHAPE
reactivity proﬁles obtained with 1M7 and NMIA were highly
reproducible and very similar. The electropherograms of a typical
region at positions 20–74 obtained by 1M7 and NMIA modiﬁcation
are shown in Fig. 2A and B, respectively. Strikingly, the core leader-
TRS sequence at nts 60–72 and the ﬂanking region showed high
SHAPE reactivity, as expected, because these regions in MHV are
predicted to be weakly paired or unpaired (Chen and Olsthoorn,
2010; Liu et al., 2007).
Three independent experiments were carried out for each
reaction and the raw electropherograms containing SHAPE reactiv-
ity versus nucleotide position were analyzed using ShapeFinder as
described in Materials and methods to yield quantitative SHAPE
reactivities at single nucleotide resolution. The mean SHAPE reac-
tivity data for 1M7 modiﬁed in vitro transcribed RNA corresponding
to nts 1–489 plus a 24 nts unstructured region is shown for nts 18–
457 in Fig. 3. Quantitative SHAPE results were not obtained for the
50- most 17 nts and for nts 458–474 at the 30 end of the target
sequence. The data shown in Fig. 3A is the average SHAPE reactivity
obtained using a primer complementary to position 261–282 near
the mid-point of the target sequence. Fig. 3B displays data obtained
using a primer complementary to the unstructured primer binding
site included in the in vitro transcribed RNA 30 to nt 489. The
experimental reproducibility was excellent.
SHAPE analysis informs a secondary structure model of the 50 474 nts
cis-acting region required for replication of MHV-A59 DI RNA
The mean SHAPE reactivity results obtained with 1M7 for the 50
474 nts segment of in vitro transcribed and refolded RNA repre-
senting the MHV-A59 genome (see Fig. 3) were imported into
RNAstructure, incorporating the SHAPE reactivity as pseudo-free
energy constraints as described in Materials and methods. The
secondary structure prediction from RNAstructure, annotated by
the nucleotide resolution SHAPE reactivity, is shown in Fig. 4. A
similar analysis was performed with the NMIA-derived mean
SHAPE reactivity as the input into RNAstructure (Fig. S1), and the
secondary structure generated for in vitro transcribed and refolded
RNA was identical with that obtained using 1M7 as the modiﬁca-
tion reagent (compare Fig. 4 with Fig. S2).
The structure generated (Fig. 4) is in agreement with our
previous characterization of SL1 (Li et al., 2008), SL2 (Liu et al.,
2009a, 2007) and predicts the correct structure for SL4 at position
nts 80–130 (Yang et al., 2011). These stem–loops serve as cis-acting
elements required for driving subgenomic RNA synthesis. Inter-
estingly, the stem predicted for SL3 by phylogenetic algorithms
(Chen and Olsthoorn, 2010) in the TRS region was single-stranded
with relatively high SHAPE reactivity, consistent with the predic-
tion of Liu et al. (2007) that this region was weakly paired or
unpaired. The structure was also in good agreement with the two
recent models of MHV-A59 RNA secondary structure (Guan et al.,
2012, 2011) that identiﬁed two additional cis-acting replication
elements required for optimal viral replication. S5 (Fig. 4) which
contains a long-range RNA–RNA interaction (nts 141–167 base
paired with nts 363–335) was largely equivalent to the base
pairing (nts 141–170 paired with nts 363–332) predicted by
Guan et al. (2012). The sole exception is nts 332–334, which are
unpaired in the Guan model but are part of the SL5C stem in our
model. SL5A (nts 171–225) was identical to the stem–loop
Fig. 2. Electropherograms of a typical region at position nts 20–74 of in vitro
transcribed and refolded RNA. In vitro transcribed and refolded RNA was reacted
with either (A) 1M7 or (B) NMIA and the samples were analyzed by primer
extension using ﬂuorescently labeled primers complementary to position 261–282.
The leader core TRS region spans nts 60–72. The blue channel represents the
modiﬁcation reaction extended with the FAM-labeled primer; the green channel
represents the control reaction with DMSO extended with the JOE-labeled primer;
the red channel is the sequencing reaction with ddA terminator, displaying a U
ladder, and the ROX-labeled primer. The gray channel is empty. The vertical axis,
labeled SHAPE reactivity, represents ﬂuorescence intensity and the horizontal axis
is the elution time aligned to the nucleotide reference sequence (NC_001846).
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designated as SLIV previously (Brown et al., 2007; Guan et al.,
2011). Furthermore, SL5A is remarkably similar to a stem–loop,
predicted and designated SL5 by Chen and Olsthoorn (2010) based
upon a structural-phylogenetic analysis of the 50UTRs of betacor-
onaviruses. SHAPE analysis has also provided biochemical support
for SL5B, SL5C, SL6 and SL7 (although we have no SHAPE reactivity
data for nts 458–474 in SL7), which, in MHV, previously lacked
support from any genetic or biochemical studies.
Nucleotides 238–262 and nts 284–309 make up a segment of
the bulged stem–loop designated SL5B in our SHAPE-generated
model, and correspond to an identical stem–loop structure that was
predicted as the basal segment of SLV (nts 238–262 and nts 284–309)
for betacoronavirus by Mfold and by covariation analysis (Brown
et al., 2007), and as part of an unnamed stem–loop by a structural-
phylogenetic analysis of betacoronavirus (Chen and Olsthoorn, 2010).
The SHAPE-generated model differs from earlier models in that, nts
234–237 are base-paired with nts 314–310 in the base of SL5B but
these nucleotides are not included in SLV (Brown et al., 2007) or the
corresponding region in Chen model (Chen and Olsthoorn, 2010).
Moreover, the structure predicted by SHAPE analysis for nts 263–283
in the terminal part of SL5B agrees with that predicted by the Chen
model (Chen and Olsthoorn, 2010), but is different from the stem–
loop predicted for the terminal portion of SLV by Brown et al. (2007).
BCoV SLV (nts 239–310) is also supported by RNase structure probing
Fig. 3. The mean 1M7-derived quantitative SHAPE reactivity for in vitro transcribed and refolded RNA. (A) Data generated with the primer complementary to position
261–282; (B) data generated with the primer complementary to the 30 end MHV-unrelated unstructured region present in in vitro transcribed RNA. All data are the means
from independent triplicate experiments. Error bars represent standard deviations from the mean. Continuous SHAPE reactivity results for nts 18–457 (underlined) were
obtained by combining data from the analyses with the two primers. We did not obtain reliable results for the 50-most 17 nts and 30 end nts 458–474. The nucleotide
positions in MHV-A59 genome and their corresponding nucleotide sequences are shown in the horizontal axis.
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(Brown et al., 2007). SL5C (nts 315–334) is similar to the distal part of
SLVI predicted by Brown et al. (2007) and to the corresponding region
in the Chen model (Chen and Olsthoorn, 2010). BCoV SLVI has been
identiﬁed as a cis-acting element required for DI RNA replication
(Brown et al., 2007). The SHAPE-generated SL6 (nts 376–446) is
remarkably similar to SLVIII, predicted by Mfold for betacoronavirus
(Brown et al., 2007), but there is no previous structural or functional
evidence to support this prediction.
RNA secondary structures predicted by SHAPE analysis of in vitro
folded RNA and ex virio RNA are identical
Biochemical studies of in vitro transcribed and folded RNAs that
represent subsequences of larger RNA species such as viral genomes
are subject to difﬁculties due to inadvertently breaking up interacting
base pairs by leaving out of the in vitro transcribed RNAs one side of a
base-paired structure. SHAPE analysis using intact ex virio RNA
obviates this particular source of error in using in vitro transcribed
RNA for biochemical studies of RNA secondary structure. Thus we
compared the SHAPE reactivity of the 50 474 nts region of interest of
in vitro synthesized and refolded RNA and ex virio viral genomic RNA,
both modiﬁed by 1M7. Ex virio viral genomic RNA that has been
gently extracted and deproteinized before 1M7 modiﬁcation is from
authentic virion but contains no bound proteins. We obtained the
quantitative single-nucleotide SHAPE reactivity for nts 17–461 by
combining the information from two primers that provided over-
lapping datasets. All reactions and analyses were performed three
times and were highly reproducible, and the mean SHAPE reactivity
Fig. 4. The secondary structural model of 50 474 nts of MHV-A59 generated by SHAPE analysis. In vitro transcribed and refolded MHV RNA corresponding to the 50-most 474 nts of
the genome was modiﬁed by 1M7 and analyzed by SHAPE using two primers (see text). Mean SHAPE reactivity data was imported into RNAstructure and the structure shown
was generated as described in Materials and methods. Nucleotides in red have average SHAPE reactivities 40.8 after normalization; nucleotides in purple have average SHAPE
reactivities between 0.5 and 0.8; nucleotides in green have average SHAPE reactivities between 0.2 and 0.5; nucleotides in black have average SHAPE reactivities o0.2.
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for each nucleotide was calculated. The pattern of the SHAPE
reactivity in electropherograms and the quantitative SHAPE proﬁle
of ex virio genomic RNA targeting 50 474 nts region (see Fig. S3) were
very similar to those of in vitro transcribed RNA shown in Fig. 3. The
resulting secondary structure model (Fig. S4) for ex virio RNA was
identical to the model generated using the SHAPE reactivity of in vitro
transcribed RNA (Fig. 4).
SHAPE reactivity of in virio RNA
We next compared the SHAPE reactivity proﬁles of in vitro
transcribed RNA and ex virio genomic RNA to that of an in virio
genomic RNA in an effort to identify the differences in SHAPE
reactivity that might report on protection mediated by viral protein
binding. For the in virio state of genomic RNA, puriﬁed virus
containing the viral genome complexed to the nucleocapsid
(N) protein in the virion was treated immediately with NMIA. The
in virio NMIA modiﬁed genomic RNA was then extracted, followed
by primer extension using the primer complementary to position
261–282 in order to focus our analysis on the core-leader TRS
sequence (nts 60–72) which is known to bind to bacterially
expressed N protein N-terminal domain with 10 nM afﬁnity (Baric
et al., 1988; Grossoehme et al., 2009; Keane et al., 2012; Nelson
et al., 2000; Stohlman et al., 1988). We obtained quantitative single-
nucleotide SHAPE reactivity for nts 21–230 from triplicate experi-
ments. Surprisingly, the pattern of SHAPE reactivity in electropher-
ograms and the quantitative SHAPE proﬁle of in virio genomic RNA
in this region are similar to those of in vitro transcribed RNA and ex
virio genomic RNA (Fig. 5). The core and the adjacent region of
leader-TRS demonstrated high SHAPE reactivity with NMIA
(Fig. 5A), similar to those of in vitro transcribed RNA modiﬁed with
NMIA (see Fig. 2B) and ex virio genomic RNA modiﬁed with 1M7
(Fig. 5B). The high SHAPE reactivity of the in virio TRS suggests that
either intact N protein does not interact strongly with the TRS in
RNA packaged into virions (Chang et al., 2013; Chen et al., 2007;
Ma et al., 2010; Takeda et al., 2008), or any complex that is formed
is such that the 20 OH moeities are not strongly protected from
NMIA modiﬁcation. A structure of this complex is not yet known
although nucleobase-aromatic stacking, which would place the 20
OH on the “outside” of the protein–RNA complex, is known to occur
and is critically important for sgRNA replication (Grossoehme et al.,
2009).
Fig. 5. A comparison of SHAPE reactivities of in virio genomic RNA and ex virio genomic RNA. The electropherograms of the region from nts 20–74 of (A) in virio genomic RNA
after NMIA modiﬁcation and (B) ex virio genomic RNA after 1M7 modiﬁcation using the primer complementary to position 261–282 for primer extension are shown. The
leader core TRS region spans nts 60–72. The blue channel represents the modiﬁcation reaction extended with the FAM-labeled primer; the green channel represents the
control reaction with DMSO extended with the JOE-labeled primer; the red channel is the sequencing reaction with ddA terminator, displaying a U ladder, and the ROX-
labeled primer. The gray channel is empty. The vertical axis, labeled SHAPE reactivity, represents ﬂuorescence intensity and the horizontal axis is the elution time aligned to
the nucleotide reference sequence (NC_001846).
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One of the goals in this work was to obtain biological insights of
MHV by SHAPE analysis that may not be obtainable using in vitro
synthesized and refolded RNAs. We compared the RNA secondary
structure of the 50 474 nts of MHV-A59 genome in the virion (in
virio) to the structure of genomic RNA that had been gently
extracted and deproteinized (ex virio) and to the structure of an
in vitro synthesized RNA, in order to identify differences in SHAPE
reactivity among the three biological states of RNA that might
allow us to infer protein binding sequences/structures within this
region of the genome, as has been done for the HIV nucleocapsid
interaction with the HIV genome (Wilkinson et al., 2008). One
possibility was that encapsidation of genome RNA by the N protein
(Sturman and Holmes, 1983) would decrease overall in virio SHAPE
reactivity and that the TRS region would display a comparatively
lower level of SHAPE reactivity due to tight binding to the
N-terminal domain of the N protein (Baric et al., 1988;
Grossoehme et al., 2009; Keane et al., 2012; Nelson et al., 2000;
Stohlman et al., 1988). However, the pattern of the SHAPE
reactivity of in virio genomic RNA for nts 21–230, which includes
the TRS region, was similar to that of our in vitro transcribed RNA
and to ex virio genomic RNA, and the three states of RNAs
generated the same secondary structures in this region.
The secondary structure of the MHV-A59 50 region obtained by SHAPE
analysis is generally similar to the RNAstructure-based models for
BCoV and for SARS-CoV
Fig. 1 shows the comparison of the secondary structure of MHV-
A59 informed by SHAPE analysis (Fig. 1A) with the most thermo-
dynamically stable models of the 50 most 474 nts of BCoV-Mebus
(Fig. 1B) and SARS-CoV (Fig. 1C) generated by RNAstructure software
without incorporating any SHAPE reactivity data, highlighted by
conserved SL1, SL2 and SL4 secondary structure elements and a four-
helix junction, SL5ABC. In general, the overall conﬁguration of the
three models is remarkably similar despite the relatively high
divergence of the nucleotide sequence. This includes a conserved
SL5ABC four-helix junction, a ﬁnding strongly consistent with a
conserved core architecture (Laing and Schlick, 2009). The lengths of
connecting single-stranded junctions between the helices are also
generally similar or identical, although the single stranded junctions
between SL5A and the other two helices (S5 and SL5B; see Fig. 1)
appear shorter for BCoV than they are in MHV or SARS-CoV. The
majority of the RNAstructure-based model for BCoV-Mebus (Fig. 1B)
is in good agreement with the model for the 50UTR and N-terminal
nsp1 coding region of BCoV generated by Mfold modeling, phyloge-
netic covariation, biochemical and genetic studies (Brown et al.,
2007; Chen and Olsthoorn, 2010; Guan et al., 2012, 2011; Kang et al.,
2006; Liu et al., 2007; Raman et al., 2003; Raman and Brian, 2005),
although the nomenclature is not equivalent. Parts of the
RNAstructure-based model for SARS-CoV (Fig. 1C) are also similar
to the model for the 50 proximal sequence of SARS-CoV developed
through structural-phylogenetic analysis. This is especially true for
substructures, SL5A, 5B and 5C, the ﬁrst two of which have been
proposed to function in genomic RNA packaging (Chen and
Olsthoorn, 2010). Based upon prior functional studies of SL1-SL4,
SL5ABC or the corresponding regions in three CoVs (Brown et al.,
2007; Guan et al., 2012, 2011; Kang et al., 2007; Li et al., 2008; Liu et
al., 2009a, 2007, 2006; Raman et al., 2003; Raman and Brian, 2005;
Yang et al., 2011) we conclude that these secondary structures serve
as common cis-acting signals important in CoVs replication and viral
RNA synthesis, with the structural features of SL1, SL2 and SL4
appearing to be more important than the precise nucleotide
sequences in these stem–loops.
A notable difference amongst the three RNAstructure-based
models is the presence or absence of SL3. In BCoV and SARS-CoV,
SL3 overlaps the leader (TRS-L) which deﬁnes the leader–body
junction region for discontinuous sgRNA synthesis. In MHV-A59,
this region was predicted to be weakly paired or unpaired (Chen
and Olsthoorn, 2010; Liu et al., 2007), a prediction supported by
our SHAPE analysis (Fig. 4). A second difference amongst the three
structures is the position of the initiation codons for nsp1; they are
similarly located for MHV and BCoV, in SL5A in MHV and BCoV,
whereas the initiation codon for SARS-CoV nsp1 is in a more 30
position, in the ﬁrst part of the 30 side of S5, as shown in Fig. 1.
Previously an attempt to create an MHV chimeric virus in which
the entire MHV 50UTR was replaced by the SARS-CoV 50UTR failed,
even when the MHV leader TRS was substituted for the SARS-CoV
TRS (Kang et al., 2006). The likely explanation for this failure is the
different locations for the initiating AUGs of the two viruses. Thus
the replacement of the MHV 50UTR with the SARS-CoV 50UTR
would disrupt the long-range interaction in S5. Similarly, the BCoV
32 nts region (nts 142–173) could not directly replace the
corresponding 30 nts sequences in MHV-A59 without genetic
adaptation (Guan et al., 2011), which is likely explained by partial
disruption of base-pairing in S5, a long-range interaction between
this region (nts 142–173) and sequences approximately 200 nts
downstream within the nsp1 coding sequence in both MHV and
BCoV. Following S5, the structures generated by RNAstructure are
somewhat more divergent amongst the three viruses with MHV-
A59 and BCoV-Mebus being relatively similar, although SL6 and
SL7 are predicted to be in a forked stem–loop structure for BCoV
whereas for MHV they form separate stem loops, and for SARS-
CoV, three stem–loops, SL6, SL7 and SL8, are predicted.
SL5C is not required for viral replication
We next performed a series of reverse genetic experiments to
determine the functional role of SL5C (nts 315–334) and SL6 (nts
376–446) in MHV-A59 replication. SL5C (nts 315–334) is similar to
the distal part of SLVI predicted by Brown et al. (2007) in BCoV and
to the corresponding region in the Chen model (Chen and
Olsthoorn, 2010). SLV (nts 239–310) and SLVI (nts 311–340) in
BCoV RNA have been supported by RNase structure probing and by
nucleotide covariation among closely related betacoronaviruses,
and SLVI has been identiﬁed as a cis-acting element required for DI
RNA replication (Brown et al., 2007). To determine the functional
importance of the secondary structure and sequence of SL5C, four
nucleotide mutations on both sides of the SL5C stem predicted by
the Vienna RNA and Mfold webservers to disrupt its helical
structure (Fig. 6A) were introduced into the cDNA representing
the 50 region of the viral genome as described in Materials and
methods. These mutations were designed to be coding silent and
preserve the translated amino acid sequence in nsp1.
An in vitro synthesized RNA containing the SL5C mutations but
otherwise identical to the wild type in vitro synthesized RNA used
previously was reacted with 1M7 and subjected to SHAPE analysis.
SHAPE data was imported into RNAstructure, incorporating the
SHAPE reactivity as pseudo-free energy constraints as described in
Materials and methods, and RNA secondary structure generated.
The SL5 portion of the predicted secondary structure is shown in
Fig. S5. The conﬁguration, position, and stability of the SL5Cstem–
loop were signiﬁcantly changed from those of the wild RNA with
an increase in the spacing between SL5B and SL5C, the SL5C stem
being shortened and less stable, and the length of the SL5C loop
increasing from 3 to 8 nucleotides. Virus was generated from the
mutant cDNA as described inMaterials and methods. Viable viruses
containing these mutations were recovered, plaque puriﬁed and
sequenced to verify the presence of the introduced mutations in
the recovered virus. No second-site substitutions were found in
the mutated region or in the sequences ﬂanking SL5C (nts 20–500).
The recovered mutant virus had only moderate impairment of virus
replication compared to that of the WT virus, as assessed by relative
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plaque size and one-step growth kinetics (Fig. 6B and C), suggesting
that the wild type cis-acting SL5C is not required for viral replication.
This contrasts to the data obtained with a BCoV DI model replicon
where the destruction of the distal helix that corresponds to SL5C
resulted in DI RNA which failed to replicate suggesting that SL5C
functioned as a cis-acting structure in that context (Brown et al.,
2007). We have previously found similar discordant results with
MHV DI RNAs and recombinant viruses containing identical muta-
tions in their 30 UTRs (Johnson et al., 2005), and subsequently with
recombinant MHVs containing SL4b mutations (Yang et al., 2011)
when compared with a BCoV DI RNA containing similar mutations
(Raman et al., 2003). Currently we reason that the nature of DI
replication assays, in which a mutant DI RNA must compete with
helper wild type virus and recombinant WT DI RNAs that arise
during the experiment, allows DI replication experiments to magnify
modest decreases in ﬁtness observed in straight forward viral
replication assays that focus on recovering viable viruses, making
them much more severe or lethal in DI RNA replication assays. An
alternative possibility not examined in this work is that any small
stem loop is allowed in place of SL5C.
SL6 is also not required for viral replication
For this set of experiments we divided SL6 into four regions using
internal bulges as landmarks (Fig. 7A): the base of the stem (nts
376–385 and nts 435–446), the middle portion of the stem (nts 386–
398 and nts 423–434), the distal segment of the stem (nts 399–407
and nts 412–422) and the terminal loop (nts 408–411) to examine
their functional role in viral replication separately.
In an earlier study of MHV nsp1 Brockway and Denison (2005)
constructed a virus, VUSB4, containing a charge-to-alanine mutation
[CAC-GCA (H57A)] at nts 378–380. This mutation is predicted by
both Vienna RNA and Mfold to destabilize the base of SL6 while
leaving the remainder of SL6 intact. VUSB4 was viable although its
replication phenotype was somewhat impaired (Brockway and
Denison, 2005), indicating that the stem at the base of SL6 is not
required for viral replication.
To determine the functional importance of structure and
sequence of the remainder of SL6, mutations were introduced into
the middle (SL6-A mutations, Fig. 7A) and distal portions (SL6-B
mutations) of the SL6 helix and the terminal loop of SL6 were
targeted individually or together (SL6-AB mutations) by introducing
multiple point mutations into the cloned cDNA representing the 50
Fig. 7. Mutational study of SL6. (A) SL6 was divided into segments, the base (nts
376–385 and nts 435–446), the middle (nts 386–398 and nts 423–434), the distal
portion (nts 399–407 and nts 412–422) and the terminal loop (nts 408–411) and
these divisions are reﬂected by horizontal lines in the ﬁgure. The names of all the
mutants in the ﬁgure are in a bold italicized font. Mutant SL6-A contains multiple
mutations in the middle segment of SL6; SL6-B contains multiple mutations in the
distal portion of SL6; SL6-C contains mutations in the terminal loop of SL6; SL6-AB
includes the mutations from both SL6-A and SL6-B. The arrows show the
introduced multiple mutations at the corresponding nucleotide sequences and
the resulting amino acid substitutions in each part. Mutations in SL6-Base, CAC-
GCA (H57A) at position nts 378–380 are from a charge-to-alanine mutant virus,
VUSB4, constructed by Brockway and Denison (2005). The amino acid changes
resulting from the introduced nucleotide changes are shown adjacent to the
nucleotide changes. The potential structures after introducing multiple mutations
at each part were predicted by the Vienna RNA and Mfold webservers. (B) Average
plaque sizes of four mutant and wild-type viruses were determined as described in
Materials and methods. (C) A one-step growth curve was determined at a MOI¼3, as
described in Materials and methods. The error bars represent the standard errors of
the mean.
Fig. 6. Mutational study of SL5C. (A) The coding silent mutations introduced into SL5C are shown. (B) Average plaque sizes were determined as described in Materials and
methods. (C) A one-step growth curve was determined at a MOI¼3, as described in Materials and methods. Error bars represent the standard errors of the mean.
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region of the genome and then used the mutated cDNAs to
regenerate virus, as described in Materials and methods. Mutations
were coding silent whenever possible, and where that was not
possible we restricted our mutations to those that resulted in
conservative (structurally, or present in the corresponding position
in BCoV) amino acid changes. Each of the potential structures in the
tested regions was predicted using the Vienna RNA and Mfold RNA
webservers. The SL6-A mutations (Fig. 7A) were predicted to open up
the targeted middle helix region but also were predicted to disrupt
the basal helix and form two new stem–loop structures, one in the
left side (nts 377–390) of the base of SL6 and the second in the right
side (nts 428–444) of the base of SL6, while keeping the structure of
the distal region of SL6 unchanged. Mutant SL6-B targeting the distal
helix was predicted to completely open up the distal region of the
SL6 stem loop and alter the structure of the middle region while
keeping the base of SL6 unchanged. To interrogate the terminal loop,
mutant SL6-C (Fig. 7A) containing three point mutations (C409G/
U410A/U411G) was made. Viable viruses containing the introduced
mutations were recovered for each of these three sets of mutations
(SL6-A, SL6-B, SL6-C). We then constructed an additional mutant,
designated as SL6-AB, which contained the mutations of SL6-A in the
middle part of the SL6 helix, with the mutations of SL6-B in the distal
portion of the SL6 helix. This mutant was predicted to destroy the
overall structure of SL6. We also recovered viable virus containing
this mutation. All four mutant viruses had only small to moderate
impairments of viral replication compared to those of the WT virus,
as assessed by relative plaque size and one-step growth kinetics
(Fig. 7B and C). The sequencing results for the mutated regions and
the ﬂanking regions (nts 20–500) of three or four plaque-puriﬁed
isolates of each mutant at virus passage 1 showed that each
contained the desired mutations with no other substitutions, with
the exception of one isolate of SL6-A which contained a 27-
nucleotide insertion between nts 70 and 71 which was a 27-nts
repeat of nts 44–70, in addition to the introduced mutations.
However, the phenotype of this isolate was identical to the other
isolates containing only the introduced SL6-A mutations in terms of
relative plaque size and titer achieved (data not shown).
To verify that the predicted mutations in SL6 did result in
alterations in SHAPE reactivity and SHAPE informed secondary
structure predictions, we separately in vitro synthesized three
RNAs containing the SL6-A, SL6-B, and SL6-AB mutations, but
otherwise were identical in sequence to the wild type in vitro
synthesized RNA used previously. These RNAs were reacted with
1M7 and subjected to SHAPE analysis. SHAPE data was imported
into RNAstructure, incorporating the SHAPE reactivity as pseudo-
free energy constraints as described in Materials and methods, and
RNA secondary structures generated. The corresponding SL6-A
mutant SHAPE-informed RNAstructure predicted secondary struc-
ture is shown in Fig. S6. The mutations have induced a major
structural change from the wild type structure, where the distal
portion of SL6 now folds into a bifurcated structure containing two
new loops. As can be seen in Fig. S7, the bracketed region,
corresponding to the loop spanning nts 416–421, is more SHAPE
reactive in the SL6-A mutant RNA than in the wild type RNA. A
similar analysis was performed using the SHAPE data obtained
with the SL6-B and SL6-AB mutant RNAs. As can be seen in Fig. S6,
the SL6-B and SL6-AB mutations also produced large pertubations
in the structure of SL6, with the SL6-AB mutation completely
restructuring the region between positions 376 and 473. Never-
theless, as noted above, viral genomes containing each of these
SL6 mutations were still able to regenerate infectious virus with
only modest defects in their ability to replicate (Fig. 7B and C).
SL6 spans nts 376–446 in MHV-A59 and encodes nsp1 amino
acid positions 56–79. The results of our mutational study (Fig. 7)
demonstrate that MHV SL6 is not essential for viral replication. In
a previous study by Brockway and Denison (2005) a genome
(designated VUSB5) containing nsp1 charge-to-alanine mutations
at nts 399–401, CGG-GCA (R64A), and at nts 414–416 GAA-GCA
(E69A) was not viable. These mutations are predicted to destabi-
lize the distal stem of SL6. A second mutation, VUSB6, includes
substitutions at nts 441–446, CGUGAU-GCAGCA (R78A, D79A),
was also not viable. Because the RNA secondary structure in these
putative cis-acting regions was not known at the time, Brockway
and Denison (2005) could not unequivocally assign the functional
effects of these mutations on replication to the amino acid
alterations in nsp1. Modeling the effects of these mutations on
the secondary structure of SL6 indicates that VUSB5 would
destabilize the distal portion of SL6 and VUSB6 is predicted to
completely open up the bottom of SL6. In light of the viability of
our mutations that greatly alter the structure of SL6 (Fig. S7), and
the ability of Brockway and Denison (2005) to recover viable
viruses containing mutations (VUSB4) in nsp1 that are predicted to
destabilize the base of SL6 very much as did the lethal VUSB5, it is
very likely that the lethality of VUSB5 and VUSB6 is due to their
effects on nsp1 structure and function rather than due to effects on
RNA secondary structure. The structural comparison in Fig. 1
shows that SL6-7 in MHV-A59 diverges somewhat from the
corresponding structures in BCoV-Mebus, and is quite different
from SL6-8 in SARS-CoV. This is consistent with our functional
studies of SL6 which demonstrate that SL6 is not essential for MHV
replication, in contrast to structural elements that are entirely
within the 50UTR (SL1, SL2, SL4) or which extend from the 50UTR
into the nsp1 coding sequence (S5), which are lethal or result in
viruses that are crippled for viral replication (Guan et al., 2012,
2011; Li et al., 2008; Liu et al., 2009a, 2007; Yang et al., 2011).
Conclusions
In this work, we use SHAPE methodology to determine the
secondary structures formed by the 50-most 474 nts in the MHV-
A59 genome. The secondary structures generated by SHAPE
analysis are in agreement with those from previous studies. This
work is the ﬁrst description of the secondary structures encom-
passing the complete minimal 50 cis-acting regulatory region
required for replication of MHV-A59 DI RNAs used as model RNA
replicons (Kim et al., 1993; Luytjes et al., 1996). The structural
model generated for MHV is generally conserved for the other
betacoronaviruses. SHAPE analysis can obtain structural informa-
tion for any size RNA, including complete RNA genomes, and is
able to identify structures involving long-range RNA–RNA interac-
tion, such as S5 in this work. Additionally we have clariﬁed our
understanding of the cis-acting elements that essential for coro-
navirus replication, demonstrating that the SL5C and SL6 stem–
loop structures previously implicated as being essential for DI
replication (Brown et al., 2007) are not essential for replication of
the intact virus. Furthermore, we successfully establish the use of
SHAPE analysis (Merino et al., 2005; Watts et al., 2009) to probe
the RNA secondary structure of genomic RNA puriﬁed from
coronavirus particles rather than on a synthetic RNA fragment.
Identical structures were generated by SHAPE analysis of MHV-
A59 ex virio genomic RNA and an in vitro synthesized and refolded
RNA representing the 50-most 489 nts of the genome, giving us a
high degree of conﬁdence in the model. Because of its relatively
high throughput nature, SHAPE analysis has the potential to
provide a secondary structure model for the entire CoV RNA
genome puriﬁed from virion particles (see Figs. S3 and S4). This
methodology will be useful to map the detailed and long range
secondary structures within genomic RNA from authentic viral
particles, particularly to determine the interactions of the inter-
genic regions and their ﬂanking sequences which likely play a role
in regulating template switching during MHV sgRNA synthesis.
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Materials and methods
Cells and virus production
DBT cells were maintained at 37 1C and 5% CO2 in DMEM
supplemented with 10% calf serum. MHV-A59 (Leibowitz et al.,
1981) was used to infect DBT cells at MOI¼0.1 and propagated for
24 h. The supernatants were harvested and clariﬁed by centrifuga-
tion at 10,000 rpm for 30 min. Baby hamster kidney cells expres-
sing the MHV receptor, Ceacam1a, (BHK-R) (Dveksler et al., 1991;
Yount et al., 2002) were originally provided by Ralph Baric
(University of North Carolina at Chapel Hill) and maintained at
37 1C and 5% CO2 in DMEM supplemented with 10% calf serum,
10% tryptose phosphate broth, 800 mg/ml of Geneticin (G418
sulfate; Sigma) to select for cells expressing the MHV receptor,
100 I.U./ml of penicillin and 100 mg/ml of streptomycin. L2 cells
were maintained at 37 1C and 3% CO2 in DMEM supplemented
with 10% calf serum. MHV-A59-1000 (Yount et al., 2002) was used
as our wild type virus for mutagenesis and reverse genetic studies,
and all mutant viruses were propagated in DBT cells.
Puriﬁcation of viruses and extraction of ex virio RNA
Virus particles in clariﬁed supernatants were pelleted by ultra-
centrifugation (25,000 rpm for 3 h) through a 3 ml 30% (w/w)
sucrose cushion in an SW28 rotor. The pelleted viral particles were
resuspended in 500 μl of MSE (10 mM MOPS at pH 6.8, 150 mM
NaCl, 1 mM EDTA) and overlaid onto a 20–60% sucrose gradient and
centrifuged in an SW41 rotor at 25,000 rpm overnight and the virus-
containing opalescent band at a buoyant density of 1.17–1.19 was
collected. The puriﬁed viruses were diluted in MSE, pelleted by
ultracentrifugation in an SW41 rotor at 35,000 rpm for 3 h, and then
resuspended in 140 μl of PBS. The viral genomic RNAs were extracted
using the QIAamp Viral RNA Mini Kit (QIAGEN, Cat. No. 52904),
quantitated by UV absorbance at 260 nm, aliquoted (1 pmol), fol-
lowed by precipitation with 3 M sodium acetate (pH 5.5), ethanol
and 20 μg of glycogen.
SHAPE reagents
NMIA was purchased from Invitrogen. 1M7 was synthesized in
our laboratory following the procedure outlined in Mortimer and
Weeks (2007). The yield of ﬁnal product was above 70% as
determined by NMR spectroscopy.
1M7 modiﬁcation of ex virio RNA
Modiﬁcation of ex virio genomic RNAwas performed as described
previously (Mortimer and Weeks, 2007; Wilkinson et al., 2008). Ex
virio RNA (1 pmol) was dissolved in 14.4 μl of 1/2 TE, adding 3.6 μl
of prewarmed (37 1C) 5 folding buffer (250 mM HEPES pH 8.0, 1 M
potassium acetate pH 8.0, 25 mM MgCl2) and incubated at 37 1C for
10 min. The ex virio RNAwas divided equally between two tubes and
treated with either 1M7 (1 μl, 100 mM in DMSO) or neat DMSO
(1 μl) for 70 s at 37 1C. The RNA from each reaction was recovered by
precipitation with sodium acetate, ethanol and glycogen, and resus-
pended in 10.5 μl of 1/2 TE for primer extension.
Puriﬁcation of viruses, modiﬁcation by NMIA and extraction of in
virio RNA
Virus particles were puriﬁed as described above for preparing ex
virio RNA, except that the pelleted puriﬁed viruses were resuspended
in 180 μl of prewarmed (37 1C) 1 folding buffer (50 mM HEPES pH
8.0, 200 mM potassium acetate pH 8.0, 5 mM MgCl2) and incubated
at 37 1C for 15 min to ensure complete resuspension of the pellet. The
virus particles were then divided equally between two tubes (90 μl/
tube) and treated with NMIA (10 μl, 100 mM in DMSO) or neat
DMSO (10 μl) for 45 min at 37 1C. EDTA (2 μl of 100 mM solution)
was added to each tube to stop the reactions. The (þ) and () NMIA
reactions were added to 40 μl of PBS to give a total volume of 140 μl/
tube. Viral genomic RNAs were extracted using a QIAamp Viral RNA
Mini Kit as per the vendor's instructions. The (þ) or () NMIA
modiﬁed in virio RNA (0.5 pmol) was precipitated with sodium
acetate, ethanol and glycogen.
Synthesis and puriﬁcation of in vitro transcribed RNA
Because detection of RNA adducts by primer extension typically
results in the loss of structural data for 40–60 nts at the 30 end of the
RNA (Merino et al., 2005; Steen et al., 2011), the sequence of in vitro
transcribed RNA was extended to position 489 nts of MHV-A59, and
a 24 nts unstructured sequence (50- GAG TGA CTA CCT CCA AGG CCC
TTT) was added to the 30 end to obtain additional SHAPE data for the
target 50- 474 nts of MHV-A59. A DNA template for in vitro transcrip-
tion encoding the 50 489 nts of the MHV-A59 genome plus the 24 nts
unstructured region was generated by PCR. The forward primer
incorporated a SpeI site (underlined) and a promoter for T7 RNA
polymerase in the 50 end: 50- CGG CGG CAT GCT AAT ACG ACT CAC
TAT AGG GTA TAA GAG TGA TTG GCG TCC G; the reverse primer
incorporated a XbaI site (underlined) in the 50 end: 50- CGC GTT CTA
GAA AAG GGC CTT GGA GGT AGT CAC TCT AGT TGA GGC CTC CAC
CTT CTG GGG ATC CTC ATC TAC. Plasmid A (Yount et al., 2002)
containing the ﬁrst 4882 nts of the MHV-A59 genome under the
control of a T7 promoter was mixed with the forward and reverse
primers and ampliﬁed by using 5 PRIME Master Mix (5PRIME) to
generate a DNA product of 555 bp, which after SpeI and XbaI
digestion was cloned into plasmid pUC18 similarly digested with
SpeI and XbaI. The resulting plasmid was then linearized by XbaI and
RNA was synthesized in vitro following the manufacturer's protocol
for the AmpliScribeTM T7-FlashTM Transcription Kit (Epicentre). The
RNA transcript was resolved and puriﬁed by denaturing polyacryla-
mide gel electrophoresis (6% polyacrylamide, 7 M Urea, 1TBE). Full-
length RNA transcript was located by UV-shadowing, excised from
the gel, and eluted at 4 1C into 0.5 M sodium acetate (pH 5.2)
overnight. The eluted RNA was ethanol precipitated, quantitated
and stored at 80 1C. The homogeneity of the in vitro transcribed
RNA was analyzed by non-denaturing gel electrophoresis and a
single band of RNA was observed suggesting that the RNA was
unlikely to have folded into multiple conformations.
Modiﬁcation of in vitro transcribed RNA
In vitro transcribed RNA (2 pmol) in 14.4 ml of 1/2TE was
refolded by heating at 95 1C for 3 min, placing on ice for 2 min,
adding 3.6 ml of prewarmed (37 1C) 5 folding buffer (250 mM
HEPES pH 8.0, 1 M potassium acetate pH 8.0, 25 mM MgCl2) and
incubating at 37 1C for 30 min. The folded RNAwas divided equally
between two tubes and treated with either 1M7 (1 ml, 100 mM in
DMSO) or neat DMSO (1 ml) for 70 s at 37 1C. The RNA from the (þ)
and () 1M7 reagent experiments was recovered by precipitation
and resuspended in 10.5 ml of 1/2 TE for primer extension. In
parallel, the same amount of folded RNA was also treated by either
NMIA (1 ml, 100 mM in DMSO) or neat DMSO (1 ml) for 45 min at
37 1C and recovered by ethanol precipitation for primer extension.
Primer synthesis and labeling for SHAPE analysis
Two sets of primers were designed for detection of ex virio RNA
and in vitro transcribed RNA targeting the MHV-A59 50-most 474 nts.
A primer (50- ATG CGT TCG GAA GCA TCC ATG G) complementary to
position 261–282 at the mid-point of the target sequence was used
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for both in vitro transcribed and virion RNAs. A primer (50- CTA CCG
AAC TGC AAT GCC ATC A) complementary to position 490–511 was
used for analyses of genome RNA modiﬁed ex virio or in virio to
obtain the SHAPE data for the target 50 474 nts of MHV-A59, and the
primer (50- GGC CTT GGA GGT AGT CAC TC) complementary to the
non-MHV unstructured extension of the 30 end of in vitro transcribed
RNA. Primers contained a 50 six carbon linker terminating in a
primary amine. The amine-tethered DNA primers were labeled with
one of three ﬂuorophores, 5-FAM, 6-JOE, or 5-ROX purchased from
AnaSpec, Inc. following a protocol from Invitrogen for labeling
amine-modiﬁed oligonucleotides. Labeled primers were precipitated
and puriﬁed by denaturing gel electrophoresis (20% 29:1 acrylamide/
bisacrylamide). Spectrophotometric measurements indicated label-
ing efﬁciencies were greater than 95% as determined by the [dye]/
[DNA] absorbance ratios.
Primer extension and capillary electrophoresis for SHAPE analysis
In vitro transcribed RNA (1 pmol), ex virio RNA or in virio RNA
(0.5 pmol) from the (þ) and () 1M7 or NMIA reactions were
used as templates for primer extension. 5-FAM ﬂuorescently
labeled primers (1 ml, 2 pmol/ml) were mixed with the 1M7 (þ)
or NMIA (þ) treated RNAs, whereas 6-JOE labeled primers (1 ml,
2 pmol/ml) were added to the control RNAs () treated with
vehicle (DMSO). Primers were annealed to the RNA by incubating
at 65 1C for 5 min followed by 35 1C for 10 min, and then placed on
ice. Primer extension was initiated by addition of reverse tran-
scriptase mix (4 ml of 5ﬁrst-strand buffer, 2 ml of 0.1 M DTT, 1 ml
of 10 mM dNTPs), and annealing at 52 1C for 1 min, followed by
the addition of Superscript III reverse transcriptase (1 ml, 200 U,
Invitrogen) and continued incubation at 52 1C for 15 min. Reac-
tions were terminated with EDTA (2 ml, 100 mM). In vitro tran-
scribed RNA not treated with 1M7 or NMIA served as template
for a single dideoxy (ddATP) sequencing reaction to align peaks
of SHAPE reactivity to the sequence of the in vitro transcribed
RNA. For the sequencing reaction of ex virio RNA, a longer in vitro
transcribed RNA of approximate 900 nts (1 pmol, 9.5 ml in
1/2 TE) was used as template. This RNA was the in vitro tran-
scription product from ScaI linearized Plasmid A DNA template
and was puriﬁed by PAGE. The sequencing reactions were carried
out using the same procedure used for primer extension with (þ)
or () 1M7/NMIA reactions with the exception that a 5-ROX
labeled primer (1 ml, 2 pmol/ml) was used and ddATP (1 ml, 10 mM)
(Invitrogen) was added to the reverse transcriptase mix. For each
state of RNA, the three primer extension products: the (þ) 1M7/
NMIA reactions, the () 1M7/NMIA reactions, and the ddA
sequencing reaction, were combined and precipitated with etha-
nol in the presence of sodium acetate and glycogen. cDNA
fragments were resolved by capillary electrophoresis on an
Applied Biosystems ABI 3130 Genetic Analyzer. Three independent
experiments were done using independently prepared RNA
(in vitro transcribed or from puriﬁed virus) as starting material.
SHAPE data processing
Raw electropherograms containing ﬂuorescence intensity versus
elution time were analyzed using ShapeFinder software that was
generously provided by the authors (Vasa et al., 2008). Raw sequen-
cer traces were processed for ﬁtted baseline adjustment, signal decay
correction, ﬁlter convolution and scale factor. Quantitative SHAPE
reactivities for individual datasets were normalized by ﬁrst excluding
the negative peak intensities which contained high background in
the () reagent control reaction, calculating the average of the 8%
most reactive peak intensities, and then dividing all of positive peak
intensities by this average. SHAPE reactivities from each primer
extension reaction were normalized independently. For each state
of RNA, the continuous SHAPE reactivity results targeting the 50 474
nts of the MHV-A59 genome were obtained by combining the
information from two overlapping reads produced from the two
primers covering the target, meaning that the ﬁrst part of the SHAPE
data was generated from the primer complementary to positions
261–282, and the second part of the data was generated from the 30
primer corresponding to nts 490–511 for genome RNAs. For in vitro
transcribed RNAs, a primer corresponding to the added 30 unstruc-
tured region was used in place of the 490–511 primer.
Incorporation of SHAPE intensities into RNAstructure
The combined SHAPE reactivity results targeting the 50 474 nts of
MHV-A59 genome for each state of RNA were imported into
RNAstructure (software can be downloaded from http://rna.urmc.
rochester.edu/RNAstructureDownload.html) incorporating pseudo-
free energy constraints using ΔGSHAPE¼mln [SHAPE reactivityþ
1.0]þb. To determine the pairing persistence, structures were
computed with two sets of values for the b and m parameters,
m¼1.7 and b¼0.6 kcal/mol (Gherghe et al., 2008) or m¼2.6 and
b¼0.8 kcal/mol (default in RNAstructure software). Maximum
pairing distance was set to No limitations. In order to generate an
accurate secondary structure for SL1 and SL2, SL2 (see Fig. 1) was
forced to be single-stranded at positions 47 through 51 and base-
paired between positions 42 through 46 and positions 56 through 52.
In previous studies, SL2 has been predicted to be highly conserved in
all coronaviruses examined by minimum free energy secondary
structural modeling using ViennaRNA and by covariation analysis
of the stem. Its existence and functional importance in subgenomic
RNA synthesis and virus replication have been demonstrated by
biophysical and reverse genetic studies (Lee et al., 2011; Liu et al.,
2009a, 2007). However, if SL2 is not forced to form, RNAstructure
generates alternative structures in the SL1 and SL2 region (not
shown) without affecting the rest of the secondary structures in
the 1-474 target RNA sequence. These same alternative structures
were also previously predicted in BCoV by Mfold (Chang et al., 1994,
1996). The ﬁnal structure for each modiﬁcation condition was based
on the most stable structure generated. Three short (2–4 nts) base-
pairings with high SHAPE reactivity were manually removed because
they were predicted to have Tm values E20 1C and thus would not
be stable under physiologic conditions, and were not present when
SL2 was not forced to base pair.
Construction of mutations in SL5C and SL6
Plasmid A was used as a substrate for site-directed mutagenesis
(Yount et al., 2002). Mutations were introduced into the desired
regions of SL5C or SL6 in MHV-A59 with the QuikChange II site-
directed mutagenesis kit (Stratagene) according to the manufac-
turer's instructions. The sequences of the oligonucleotides used for
mutagenesis are available on request. Mutagenized plasmids were
sequenced between unique MluI and BamHI restriction sites to verify
the introduced mutations. To minimize the possibility that the
plasmids used to generate mutant viruses contain unintended
mutations introduced outside the MluI–BamHI fragment, the
sequenced MluI–BamHI fragments containing the introduced muta-
tions were excised and ligated with MluI–BamHI-digested parental
unmutagenized plasmid A to generate the plasmids used to produce
mutant viruses. The sequences of these plasmids between the MluI
and BamHI sites were all veriﬁed again by sequencing.
Assembly of full-length MHV-A59 cDNAs and recovery of
mutant viruses
cDNAs representing the entire MHV-A59 genome, carrying
either the wild-type sequence or mutations in SL5C or SL6, were
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constructed by sequential ligation of digested and gel puriﬁed
cDNAs A to G and the ligated cDNA transcribed in vitro using the
Ambion T7 mMESSAGE mMACHINE kit (Applied Biosystems), as
described previously (Johnson et al., 2005; Yount et al., 2002). The
transcription reactions were then electroporated into BHK-R cells
that were then overlaid onto DBT cells. Cultures were incubated
for up to 72 h and monitored by phase microscopy for the
development of cytopathic effect (CPE). Recovered viruses were
plaque puriﬁed on L2 cell monolayers and subsequently propa-
gated in DBT cells. The mutated region and the ﬂanking region (nts
20–500) were ampliﬁed by RT-PCR and sequenced to conﬁrm the
presence of the introduced mutations and to identify any second-
site mutations in the neighborhood that might have arisen during
virus recovery and propagation. For each mutant, at least two
(usually 3) plaque-puriﬁed isolates at passage 1 (P1) were selected
for sequencing.
Plaque size determination and growth curve assays
Plaque assays were performed in L2 cells as described previously
(Johnson et al., 2005). Plaque diameters were calculated from 30
well-formed plaques for each virus. Growth curves were performed
by infecting replicate wells of DBT cells in 96-well plates with mutant
or wild type viruses at a multiplicity of infection (MOI) of 3. Triplicate
infected cultures were harvested at 0, 4, 8, 12, 16, and 24 h
postinfection (h.p.i). Virus titers were determined by plaque assays.
The Kruskal–Wallis test and one-way ANOVAwere used for statistical
comparisons amongst mutant and WT viruses. Error bars represent
the standard errors of the mean.
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